Parallax Health Sciences Announces Increased Customer Acquisition in Both Management and Diagnostics Divisions
09 avr. 2020 10h10 HE
|
Parallax Health Sciences, Inc.
Company Receives Over $10 million of Telehealth and Medical Supply Contracts from Coast to Coast NEW YORK, NY, April 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health...
Parallax Diagnostics Partners with CURE Pharmaceuticals to Distribute Individually Sealed CUREfilm® D for Medical and Critical Services Workers
07 avr. 2020 10h21 HE
|
Parallax Health Sciences, Inc.
COVID-19 Coronavirus Infection Risk May be Reduced by Weekly Dose of Vitamin D3 NEW YORK, NY, April 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB:...
Parallax Health Sciences Announces Patent Enforcement Initiative
06 janv. 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Over $500 Million in Potential Infringement Damages Present in Diagnostic and Behavioral Markets NEW YORK, NY, Jan. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences,...
Parallax Health Sciences Announces Acquisition of Minority Interest In Global Career Networks
19 sept. 2019 13h18 HE
|
Parallax Health Sciences, Inc.
SANTA MONICA, CA, Sept. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare...
Parallax Health Sciences Announces Licensing Agreement With HealthPointe Solutions
18 juil. 2019 10h23 HE
|
Parallax Health Sciences, Inc.
Cognitive Artificial Intelligence and Data Analytics Combined with Outcomes Optimization for the Healthcare Market SANTA MONICA, CA, July 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax...
Parallax Health Sciences Deemed Prevailing Party and Anticipates Impending Judgment to Collect Recovery of Prior Attorney Fees and Expenses Incurred in Relation to Melamed Rescission Matter
17 juin 2019 09h24 HE
|
Parallax Health Sciences, Inc.
SANTA MONICA, CA, June 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare...
Parallax Health Sciences, Inc. Provides First Half 2019 Shareholder Update
11 juin 2019 07h00 HE
|
Parallax Health Sciences, Inc.
Company Completes Corporate Realignment Program to Focus on Generating Revenues from Point of Care Businesses and Intellectual Property Monetization SANTA MONICA, CA, June 11, 2019 (GLOBE...